scholarly journals Primary Squamous Cell Carcinoma of the Submandibular Salivary Gland: A Rare Entity

2011 ◽  
Vol 14 (S1) ◽  
pp. 57-59 ◽  
Author(s):  
Rohith V. Gaikwad ◽  
S. V. Kumaraswamy ◽  
R. Keerthi
2015 ◽  
Vol 2015 ◽  
pp. 1-3 ◽  
Author(s):  
Tapan Kumar Sahoo ◽  
Saroj Kumar Das ◽  
Chandraprava Mishra ◽  
Ipsita Dhal ◽  
Rohani Nayak ◽  
...  

Primary squamous cell carcinoma of the renal parenchyma is an extremely rare entity. The diagnosis of squamous cell carcinoma of the renal pelvis is usually unsuspected due to the rarity and inconclusive clinical and radiological features. Most of the patients are diagnosed at an advanced stage and are with poor outcome. Radical nephrectomy is the mainstay of the treatment. We reported a case of squamous cell carcinoma of the kidney in a 50-year-old female who presented with the right sided abdomen pain. The patient was treated with radical nephrectomy.


Rare Tumors ◽  
2020 ◽  
Vol 12 ◽  
pp. 203636132097352
Author(s):  
Silvia Mezi ◽  
Giulia Pomati ◽  
Andrea Botticelli ◽  
Francesca De Felice ◽  
Daniela Musio ◽  
...  

Primary squamous cell carcinoma of salivary gland (SCG) is an extremely rare type of malignant salivary gland tumor, which in turn results in scarcity of data available regarding both its treatment and associated genetic alterations. A retrospective analysis of 12 patients with primary SCG was conducted, along with analysis of the association between treatment, clinical/pathological characteristics, and outcomes. Most patients (8) were staged IVa, with the majority of them (10) having G3 fast growing cancer. Local and systemic recurrence were reported in only three out of nine parotid cases (0 out of 2 submandibular SCGs). In two out of eight patients local relapse occurred after integrated treatment, while recurrence occurred in two out of three patients undergoing exclusive surgery. Five patients eventually died. Treatment of resectable disease must be aggressive and multimodal, with achievement of loco-regional control in order to reduce rate of recurrence and improve outcomes. Metastatic disease would require a therapeutic strategy tailored to the molecular profile in order to improve the currently disappointing results.


2013 ◽  
Vol 2013 (may24 1) ◽  
pp. bcr2013009706-bcr2013009706 ◽  
Author(s):  
M. Little ◽  
P. C. Munipalle ◽  
Y. K. S. Viswanath

Author(s):  
Miguel Fraile López ◽  
Guillermo Eduardo Mendoza Pacas ◽  
Fernando Fernández Cadenas

2014 ◽  
Vol 18 (2) ◽  
pp. 299 ◽  
Author(s):  
Vardendra Manvikar ◽  
Surekha Ramulu ◽  
ShilpaT Ravishanker ◽  
Chitra Chakravarthy

Author(s):  
HELDER DOMICIANO DANTAS MARTINS ◽  
HUMBERTO PEREIRA CHAVES NETO ◽  
BRUNO BEZERRA DE SOUZA ◽  
JOSE SANDRO PEREIRA DA SILVA ◽  
ADRIANO ROCHA GERMANO ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document